.

Team

Founded in 2015, RYSE is a diverse team with a strong investment management background combined with experience across venture capital, entrepreneurship, healthcare, research, operations, and technology.


Shabir Chowdhary

Shabir Chowdhary, Managing Partner

Shabir has a track record of building companies and supporting company founders across multiple sectors. The majority of his career has been spent building and managing asset management businesses across Europe. He was successful in developing and executing fundraising and marketing strategies that enabled collaboration with private groups and public bodies and substantial investment from a variety of highly reputable foundations, endowments, charities, pension funds, insurance companies as well as fund of funds and bank investors. Asset management businesses Shabir has been involved with have raised in excess of $4.5bn in aggregate and several sold to strategic buyers.

Shabir holds a BSc (Hons) in Biochemistry and an MBA from Imperial College London. On leaving university, he spent several years in banking with Merrill Lynch, Morgan Stanley, and Schroders.

This email address is being protected from spambots. You need JavaScript enabled to view it. LinkedIn
John Lee Allen

Dr John Lee Allen, Managing Partner

John is a venture capital investment professional with a track record across healthcare, as a physician, research scientist, and technology entrepreneur. With an engineering and biology background, his focus spans healthtech and biotech – areas where he has spoken and published widely. He developed an implantable biotech device as a neuroscience PhD student at Oxford University, leading him down the path as a serial tech entrepreneur and angel investor. He was a partner at Specsavers supporting their global expansion into hearing care and is a national NHS Clinical Entrepreneur Fellow.

John holds a degree in Medicine and Surgery from Imperial College London, an undergraduate degree in engineering, and has held innovation and research roles at the World Health Organization, National University Hospital Singapore, Johns Hopkins Hospital, and Harvard University.

This email address is being protected from spambots. You need JavaScript enabled to view it. LinkedIn Google Scholar
Eric Kostegan

Eric Kostegan, Impact Investing Lead

Eric is an impact investing and venture philanthropy leader with a 25-year track record building and leading innovative healthcare programmes and ventures globally. He has raised over $600m in capital with specific expertise working with organisations in healthcare including Mount Sinai Health System, Jefferson Health, and Mass General Brigham (Harvard) Integrated Health Care System.

Eric is based in San Francisco and is highly recognised for creating innovative, measurable, and metrics-focused programmes, to engage stakeholders and foster collaboration across healthcare.

This email address is being protected from spambots. You need JavaScript enabled to view it. LinkedIn
Vivien de Tusch-Lec

Vivien de Tusch-Lec, Venture Advisor

Vivien is an investor, entrepreneur, and has had 3 exits as a start-up founder (Infinancials, Bubele, Martialfunk). She ran the Tech, Media, Telecom unit for B2B Marketplace Gerson Lehman Group - and has been supporting the Investment Committee at RYSE. In 2018, she was a co-investor during the first investment programme with DigitalHealth.London and MedCity, in Skin Analytics and LiveSmart, and now manages a portfolio of technology investments.

Vivien loves operating in start-ups, is an advisor to Loyal VC, a former journalist, and non-exec director at Techspert.io. She holds a Masters degree from the University of Cambridge and an MBA from INSEAD.

LinkedIn
Rodrigo Mallo Leiva

Rodrigo Mallo Leiva, Venture Advisor

Rodrigo is an investor and Partner at Luminous Ventures. Formerly a Partner at SOSV, he has invested in over 45 companies at Seed and Series A, and is an active investor in digital healthcare. He is a mentor for The Founder Institute, Techstars, and is an Ambassador for the MIT Technology Review in Europe. He founded four LatAm technology companies in the food, gaming, and digital advertising industries.

Rodrigo is a Kauffman Fellow, became an angel investor after selling gaming company (TheFanLeague), and holds executive qualifications in venture capital from UC Berkeley.

LinkedIn
Dr Carina Tyrrell

Dr Carina Tyrrell, Innovation Advisor

Carina is a British-Swiss public health physician, ex-founder, and research fellow at Cambridge University. She has worked with the NHS, Clinical Commissioning Groups, local and national government, and the World Health Organization, publishing international policy and research. With government agencies and the Cambridge Judge Business School, she is working in operations and technology management, and in improving healthcare delivery. She has been identifying COVID-19 vaccine and therapeutic trials, publishing work with Oxford University.

Carina holds a degree in Medicine and Masters of Public Health from the University of Cambridge. Carina has appeared on BBC News, Sky News, Radio 4, and has been featured in The Times, Daily Telegraph, and Business Insider.

LinkedIn Google Scholar
Dr Benjamin Maddison

Dr Benjamin Maddison, Venture Advisor

Ben’s passion is creating tomorrow through scalable sustainable innovation and business transformation. His background in commercial innovation, strategy, change and project management uniquely positions him with a blend of valuable skills, knowledge and broad sector experience. This is with some of the largest global companies including Costa Coffee, owned by The Coca-Cola Company, and leading consumer healthcare brands at Unilever. His 18+ years experience spans several industries including healthcare, pharmaceutical, public sector and consumer goods. He has a proven track record on launching disruptive innovations in global markets.

Ben holds a PhD from Imperial College London, specialising in molecular neurochemistry, and an undergraduate degree in Biochemistry.

LinkedIn
Chris Turner

Chris Turner, Entrepreneur-in-Residence

Chris is an experienced entrepreneur and the founder of Dimec, a UK based digital healthcare start-up that was acquired by Co-op Health in 2018. Dimec, now Co-op Health, facilitates the ordering of repeat prescriptions by linking patients directly with their GP surgery. It was the very first GP and pharmacy integrated service, giving patients the choice of having their prescriptions delivered or to collect from any high street pharmacy in England.

Chris holds a first class Master in Pharmacy degree, is an NHS qualified pharmacist, and an NHS Clinical Entrepreneur Fellow.

LinkedIn
Annalisa Jenkins

Dr Annalisa Jenkins, Healthcare advisor

Annalisa has a 25-year track record in building and leading teams from scientific research through clinical development, regulatory approval and into healthcare systems globally. She is Chairman of the Court at the London School of Hygiene and Tropical Medicine and member of the Science Advisory Board at the FDA. She was CEO of Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases.

Annalisa holds a degree in Medicine, specialised in Cardiovascular Medicine, and served as a Medical Officer in the British Navy.

LinkedIn
James Kent

Dr James Kent, Policy Advisor

James was appointed Special Advisor on health to Theresa May in 2017. He was formerly a Partner and Managing Director at Boston Consulting Group, where he built their NHS practice. James has over 30 years of healthcare sector experience as a doctor, consultant and government advisor. He brings strategy, organisational and change management skills; clinical and health systems expertise; ability to operate within the private, public and political environments.

James trained in the NHS, is a member of the Royal College of Physicians, and holds an MBA from INSEAD.

LinkedIn
Dr Laila Samady-Mustad

Dr Laila Samady-Mustad, Partnership Advisor

Laila is a research scientist, strategic advisor, and entrepreneur with 20 years’ experience in the pharmaceutical, medical, and biotechnology industry in the UK, US, and France. Her expertise is in medical affairs, partnership, business development, and capital raising strategies. She is Chair of the Board of Advisors and Chief Scientific Officer at Vigilent Labs (digital health), Vice President at Covanos (med tech), Vice President at G3 Therapeutics (biotech), and has held several senior partnership roles at Boehringer Ingelheim.

Laila holds a PhD from University College London and her work led to a spin out company, BioVex, which was acquired by Amgen for $1Bn.

LinkedIn